August 2022 A NanoBRET-Based H 3 R Conformational Biosensor to Study Real-Time H 3 Receptor Pharmacology

April 2022 Trevena Receives up to $40M in OLINVYK ex-US Royalty-Based Financing from R-Bridge Healthcare disorders, today announced that the Company entered into a royalty-based financing with an affiliate of R-Bridge Healthcare Fund (the R-Bridge Financing)."

biosensors reveals distinct conformational signatures of β-arrestin1 and 2 when bound to active PTH1R (P-R* specifically by proximal and distal C-terminal phosphorylation and in the absence of GPCR kinases (GRKs) (R* Here, we show differences between conformational changes that are induced by P-R* or R* receptor states

GPCR Podcast << Back to podcast list Scott Struthers R. R. Scott Struthers on the web LinkedIn Google Scholar Crinetics Radionetics Dr.

Raul Gainetdinov Raul R. Before SPBU, Raul R. In 2018-2020, Raul R.

These roles included management of PerkinElmer’s BioPharma R&D program and Chair of the company’s Scientific